Executive coach Joel Garfinkle shares tips to help "quiet" life science leaders assert themselves and move from invisible to ...

Twenty years ago, Roger Cone, Ph.D. made a key discovery in obesity science which could help Courage Therapeutics deliver ...

Life sciences companies can look to the automotive industry for ideas about collaborating with patients to co-create new ...

By sharing early-stage tools and data openly, life sciences companies can minimize duplication and de-risk R&D without ...

Catalyst Flex, a functional service provider (FSP) solution of Catalyst Clinical Research, is a multi-therapeutic niche contract research organization (CRO)with flexible, fit-for-purpose offerings in ...

The business model CEO Dr. Hernan Bazan and his colleagues put in place at South Rampart Pharma was not typical for a small biotech firm.

Biotechnology is all about scientific breakthroughs that lead to transformative therapies. But despite billions invested and years of R&D, data from Deloitte found that more than half of drug launches ...

James Sapirstein, CEO at Entero Therapeutics and a 40-year biopharmaceutical industry veteran, makes a compelling case for Big Pharma partners and investors to take a chance on a cheap and safe ...

With the enthusiasm surrounding innovative product types and therapeutic approaches — and the corresponding rush to bring these new products to market — company leaders should double down on internal ...

Leading a biotech company in this dynamic industry requires a strong, agile team and a championship mindset. Applying the same strategies that led my Philadelphia Eagles to the Superbowl, just as a ...

How long should a new drug be protected against lower- cost generic or biosimilar competitors? Established patent law provides an answer, and mechanisms exist in the U.S. to challenge patents believed ...

<p>Before entering a partnership, executives need to ask themselves and their prospective partners&rsquo; key questions in the following five areas:</p> ...